A5048354846- Cancer Risks and Factors
- Multiple and Secondary Primary Cancers
- Childhood Cancer Survivors' Quality of Life
- Family Support in Illness
- Global Cancer Incidence and Screening
- Birth, Development, and Health
- Acute Lymphoblastic Leukemia research
- Pregnancy and Medication Impact
- Prenatal Screening and Diagnostics
- Breast Cancer Treatment Studies
- Cancer Diagnosis and Treatment
- Reproductive System and Pregnancy
- Ovarian cancer diagnosis and treatment
- HIV/AIDS Research and Interventions
- Assisted Reproductive Technology and Twin Pregnancy
- Pregnancy and preeclampsia studies
- Neurological Complications and Syndromes
- Breastfeeding Practices and Influences
- Hearing, Cochlea, Tinnitus, Genetics
- Brain Metastases and Treatment
- Bone health and treatments
- HIV, Drug Use, Sexual Risk
- Oral health in cancer treatment
- Renal and related cancers
- Cancer-related Molecular Pathways
Cooper University Health Care
2004-2025
Cooper University Hospital
2012-2024
Cooper Medical School of Rowan University
2012-2024
University Medical Center
2021
University Hospital and Clinics
2021
Cooper Hospital
2021
The Netherlands Cancer Institute
2021
Radboud University Nijmegen
2021
Erasmus MC
2021
Emma Kinderziekenhuis
2021
Breast cancer is the most common malignancy occurring during pregnancy. Because more women delay childbearing, diagnosis of pregnancy will likely increase. Case reports exist in literature regarding treatment pregnant with breast cancer, but few are prospective and provide long-term follow-up on neonate exposed to chemotherapy. In this report, 130 diagnosed were reported our voluntary national registry followed up prospectively.The Cancer Pregnancy Registry a that monitors clinical course,...
Objective: Because of few cases at any 1 institution, pooling information on the treatment pregnant women diagnosed with cancer and long-term follow-up their children is important. Methods: Women between last menstrual period end pregnancy were voluntarily enrolled in Cancer Pregnancy Registry. Details outcomes collected. Neonatal obtained yearly. Results: Two hundred thirty-one over a 13-year period. Thirteen elected termination. One fifty-seven neonates exposed to chemotherapy utero. Mean...
OBJECTIVE: To estimate the effect of dose-dense chemotherapy during pregnancy on maternal and neonatal outcomes. METHODS: This is a retrospective cohort study in which women were identified from international Cancer Pregnancy Registry at Cooper Medical School Rowan University Camden, New Jersey. A chart analysis was completed Fisher's exact test independent t used comparing patient RESULTS: Ten received chemotherapy, every 2 weeks, 99 conventional with least 3-week intervals, for breast...
<h3>Importance</h3> Chemotherapy during the first trimester of pregnancy should be avoided owing to risk congenital malformations. However, precise gestational age at which chemotherapy can initiated safely remains unclear. <h3>Objective</h3> To assess malformation rates associated with initiation among pregnant women cancer. <h3>Design, Setting, and Participants</h3> This multicenter cohort study evaluated all who received between 1977 2019 registered in International Network on Cancer,...
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary point, may be published when key planned co-primary or secondary analyses are not yet available. Trial Updates provide an opportunity to disseminate additional results from studies, in JCO elsewhere, for which point has already been reported. This multicenter cohort study reports long-term effects of prenatal exposure maternal cancer and its treatment...
Abstract Background : Cancer occurs during one in 1000–5000 of the approximately 6 million yearly US pregnancies identified by American Pregnancy Association. Although a newly diagnosed cancer is associated with substantial distress, little known about cancer's emotional impact on women when pregnancy, and no studies have been conducted subject. Objective The Registry was developed Elyce H. Cardonick MD, specialist Maternal Fetal Medicine Associate Professor Obstetrics Gynecology at Robert...
Background: Colorectal cancer in pregnancy is rare, with an incidence of 0.8 per 100,000 pregnancies. Advanced disease (stage III or IV) diagnosed more frequently pregnant patients. We aimed to review all cases colorectal from the International Network on Cancer, Infertility and Pregnancy database order learn about this rare improve its management.Methods: Data demographic features, symptoms, histopathology, diagnostic therapeutic interventions outcomes (obstetric, neonatal maternal) were...
Chemotherapy crosses the placenta, however, it remains unclear to what extent affects fetal growth. The current literature suggests up 21% of offspring women receiving chemotherapy are small for gestational age (SGA, birth weight <10th percentile). Limiting research weights only might misjudge growth restriction (FGR) in this high-risk population with multiple risk factors impaired Moreover, role duration and at initiation is yet poorly understood.This retrospective cohort study evaluates...